These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 8411755)

  • 1. [A case of primary biliary cirrhosis associated with chronic active hepatitis type C improved by the injection of interferon and the administration of ursodeoxycholic acid].
    Saitoh S; Yamada T; Satoh K; Makita F; Ojima T; Nishijima K; Chishima J; Yamada S; Takagi H; Nagamine T
    Nihon Shokakibyo Gakkai Zasshi; 1993 Sep; 90(9):2152-6. PubMed ID: 8411755
    [No Abstract]   [Full Text] [Related]  

  • 2. Exacerbation of primary biliary cirrhosis during interferon-alpha 2b therapy for chronic active hepatitis C.
    Maeda T; Onishi S; Miura T; Iwamura S; Tomita A; Saibara T; Yamamoto Y
    Dig Dis Sci; 1995 Jun; 40(6):1226-30. PubMed ID: 7781437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [An autopsied case of interstitial and infectious pneumonia appeared during interferon treatment for C-type chronic active hepatitis].
    Motegi K; Yamada S; Saruya S; Hayashi T; Otani N
    Nihon Shokakibyo Gakkai Zasshi; 1994 Mar; 91(3):350-4. PubMed ID: 8145375
    [No Abstract]   [Full Text] [Related]  

  • 4. Long-term efficacy of interferon-alpha and ursodeoxycholic acid in treatment of chronic type C hepatitis.
    Senturk H; Uzunalimoglu O; Batur Y; Simsek I; Mert A; Ozbay G; Cetinkaya H; Ersoz G; Tabak F; Akbaylar H; Akdogan M; Dokmeci A; Sonsuz A; Ozenirler S; Erden E; Tozum N
    Dig Dis Sci; 1997 Jul; 42(7):1438-44. PubMed ID: 9246043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Lichen planus during chronic hepatitis C treated with interferon alpha].
    d'Agay-Abensour L; Benamouzig R; de Belilovsky C; Cordoliani F; Halphen M; Rambaud JC
    Gastroenterol Clin Biol; 1992; 16(6-7):610-1. PubMed ID: 1526425
    [No Abstract]   [Full Text] [Related]  

  • 6. Oral erosive lichen planus with epidermolytic hyperkeratosis during interferon alfa-2b therapy for chronic hepatitis C virus infection.
    Schlesinger TE; Camisa C; Gay JD; Bergfeld WF
    J Am Acad Dermatol; 1997 Jun; 36(6 Pt 1):1023-5. PubMed ID: 9204077
    [No Abstract]   [Full Text] [Related]  

  • 7. Why we should treat chronic viral hepatitis.
    King PD
    Postgrad Med; 1996 Sep; 100(3):68-70, 73; discussion 73, 78. PubMed ID: 8795647
    [No Abstract]   [Full Text] [Related]  

  • 8. Serum interferon gamma in primary biliary cirrhosis: effect of ursodeoxycholic acid and prednisone therapy alone and in combination.
    Fracchia M; Secreto P; Tabone M; Zaffino C; Pera A; Galatola G
    Eur J Gastroenterol Hepatol; 2000 Apr; 12(4):463-8. PubMed ID: 10784002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and biochemical features and therapy responses in primary biliary cirrhosis and primary biliary cirrhosis-autoimmune hepatitis overlap syndrome.
    Günsar F; Akarca US; Ersöz G; Karasu Z; Yüce G; Batur Y
    Hepatogastroenterology; 2002; 49(47):1195-200. PubMed ID: 12239904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T-lymphocyte subpopulations as factors predicting clinical response to interferon in hepatitis C virus-related chronic active hepatitis.
    Guadagnino V; Caroleo B; Izzi A; De Rosa G; D'Amelio R
    Infection; 1995; 23(3):189-90. PubMed ID: 7499011
    [No Abstract]   [Full Text] [Related]  

  • 11. [Serum complement cold activation is vanished by the interferon therapy for chronic active hepatitis C patients].
    Ando B; Shimohashi N; Sumii T; Sasaki N; Furudera S; Tanaka E
    Nihon Shokakibyo Gakkai Zasshi; 1995 Oct; 92(10):1811. PubMed ID: 7474477
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical course of inflammatory bowel disease during treatment with interferon for associated chronic active hepatitis.
    Cottone M; Magliocco A; Trallori G; Brignola C; Vandelli C; Ardizzone S; Meucci G; Zannoni F; Di Maio G; Astegiano M
    Ital J Gastroenterol; 1995; 27(1):3-4. PubMed ID: 7795286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic hepatitis C complicated by Coombs-negative hemolytic anemia during interferon treatment.
    Hirashima N; Mizokami M; Orito E; Yamauchi M; Narita M; Mizuno M; Tokuda Y; Nakano T; Kato M; Matsumoto T
    Intern Med; 1994 May; 33(5):300-2. PubMed ID: 7949634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abducent nerve paralysis during interferon alpha-2a therapy in a case of chronic active hepatitis C.
    Fukumoto Y; Shigemitsu T; Kajii N; Omura R; Harada T; Okita K
    Intern Med; 1994 Oct; 33(10):637-40. PubMed ID: 7827383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic viral hepatitis and use of interferon. Whom are we treating?
    Koretz RL
    Postgrad Med; 1996 Sep; 100(3):55-7, 61-2, 68. PubMed ID: 8795646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of chronic hepatitis C with interferon with or without ursodeoxycholic acid: a randomized prospective trial.
    Abdelmalek MF; Harrison ME; Gross JB; Poterucha JJ; Gossard AA; Spivey JR; Rakela J; Lindor KD
    J Clin Gastroenterol; 1998 Mar; 26(2):130-4. PubMed ID: 9563925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomised trial of effects of interferon-alpha on incidence of hepatocellular carcinoma in chronic active hepatitis C with cirrhosis.
    Nishiguchi S; Kuroki T; Nakatani S; Morimoto H; Takeda T; Nakajima S; Shiomi S; Seki S; Kobayashi K; Otani S
    Lancet; 1995 Oct; 346(8982):1051-5. PubMed ID: 7564784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A case of chronic active hepatitis C presenting heart failure during interferon alpha 2 alpha therapy].
    Shinagawa J; Inagaki Y; Suzuki M; Atsukawa K; Yonei Y; Tsukada N; Miyamoto K; Suzuki O; Kawamura Y; Kiryu Y
    Nihon Shokakibyo Gakkai Zasshi; 1995 May; 92(5):899-903. PubMed ID: 7783385
    [No Abstract]   [Full Text] [Related]  

  • 19. Interferon alpha 2-b therapy of HCV and nonBnonC chronic hepatitis.
    Gargiulo M; Tarquini P; Di Ottavio L; Lattanzi E; De Nigris-Urbani A
    Arch Virol Suppl; 1992; 4():304-5. PubMed ID: 1450709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of granulomatous hepatitis during treatment with interferon-alpha 2b.
    Propst A; Propst T; Dietze O; Kathrein H; Judmeier G; Vogel W
    Dig Dis Sci; 1995 Oct; 40(10):2117-8. PubMed ID: 7587776
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.